top of page


International Society of Reproductive Genetics (ISRG) is a newly established organization dedicated to advancing knowledge of reproductive genetics. ISRG is committed to establish a broad platform for international communication and cooperation to promote the development of scientific research and clinical practice in the field of reproductive genetics and facilitate the access to the latest scientific knowledge and state-of-the-art technologies.

Get To Know Us



Alan Handyside, Ph.D.



Xiaoliang Sunny Xie, Ph.D.

President Elect


Zhihong Yang, D.V.M., Ph.D.

Secretary General,Co-Founder

Dr Lin.png

James Lin, M.D.,

Treasurer, Co-Founder

Professor Handyside is an internationally-recognized pioneer and expert in human embryology and preimplantation genetics with an extensive research portfolio, a track record for innovation in single-cell diagnostics, and 20 years of experience in management in the private IVF sector in the UK.  He developed the first transgenic mouse knockout of the HPRT gene using embryonic stem cells as a model of the human X-linked inherited disease, Lesch-Nyhan Syndrome, and achieved the first pregnancies worldwide following in vitro fertilization (IVF) and preimplantation genetic diagnosis (PGD) of inherited disease in 1990.  He was the first Chairman of the European Society for Human Reproduction and Embryology (ESHRE) Special Interest Group in Reproductive Genetics, co-founder and first chairman of the ESHRE PGD Consortium and Past President of Preimplantation Genetic Diagnosis International Society (PGDIS). Professor Handyside is Scientific Director at the University of Kent in Canterbury, UK, and President and Co-Founder of ISRG.

Professor Xie is a biophysical chemist. He is the Lee Shau-kee Professor at Peking University. He was the Mallinckrodt Professor of Chemistry and Chemical Biology at Harvard University until 2018. As a pioneer of single-molecule biophysical chemistry, coherent Raman scattering microscopy, and single-cell genomics, he made major contributions to the emergence of these fields. In particular, his inventions in single-cell genomics have been used in vitro fertilization to benefit thousands of couples in China by avoiding the transmission of monogenic diseases to their newborns. He is a member of the US National Academy of Sciences, US National Academy of Medicine, American Academy of Arts and Sciences, and a foreign member of the Chinese Academy of Sciences.

Professor Yang has worked in the field of assisted reproductive technology in North America for over 25 years with extensive training and research experiences. He is well-known for his pioneering work on clinical studies on Preimplantation Genetic Testing for Aneuploidy (PGT-A) and Time-lapse (TL). He was a full-time Clinical Professor at University of Pittsburg School of Medicine and the Director of Andrology, Embryology and Endocrinology Laboratories in the Great Pittsburg Medical Center (GPMC). Professor Yang is the Co-Founder and Secretary General of International Society of Reproductive Genetics (ISRG) and the Co-Chairman of Membership Committee of Preimplantation Genetic Diagnosis International Society (PGDIS).

Dr. Lin, a third generation physician, is a Reproductive Genetic Futurist and Philanthropist. For almost 30 years, Dr. Lin serves as the founder and medical director of the RFC Family of IVF Centers in America. Concurrently, Dr. Lin is also serving as CEO of Incinta Global Premier Reproductive Network and is a co-founder and executive board member of ISRG with Dr. Handyside and Dr. Yang. Poised to lead the ever changing bioethics and future technologic advancements in reproductive medicine, Dr. Lin also bridges the nonprofit work of Linfertility Family Foundation and Project “City of Life” to make IVF ubiquitous and link humanity to the future.



Dennis Lo, M.D., Ph.D.

Professor Lo is the Director of the Li Ka Shing Institute of Health Sciences at The Chinese University of Hong Kong. He discovered the presence of cell-free fetal DNA in maternal plasma in 1997. He has pioneered a number of key technologies for noninvasive prenatal testing and cancer liquid biopsies. He is a Fellow of the Royal Society and a Foreign Associate of the US National Academy of Sciences and won the Breakthrough Prize in Life Sciences (2021).

Jie Qiao.png

Jie Qiao, M.D., Ph.D.

Professor Qiao is the Executive Vice President of Peking University, Director of Peking University Health Science Center, and President of Peking University Third Hospital. Her research focus on the molecular mechanism of human gametogenesis and embryo development, infertility causes and clinical treatments, the protection and preservation of female fertility as well as the development of new preimplantation diagnosis methods. She is a member of the Chinese Academy of Engineering, American Academy of Arts and Sciences, and Royal College of Obstetricians and Gynecologists, and received the TOP 10 Progress of Chinese science, National Award for Progress in Science and Technology.


Hefeng Huang, M.D., Ph.D.

Professor Huang is an obstetrician and gynecologist, and also a Chair Professor of Fudan University.  She is a pioneer who studied the safety of assisted reproductive technology, made outstanding contributions to the prevention and control of birth defects in China through pre-implantation genetic diagnosis, and revealed the epigenetic mechanism underlying gamete-embryo origins of adult diseases.  She is a member of the Chinese Academy of Sciences, Fellow Honoris Causa of the Royal College of Obstetricians and Gynecologists, a fellow of the Third World Academy of Sciences, and a member of the Chinese Academy of Medical Sciences (CAMS).


Yanping Kuang, M.D., Ph.D.

Professor Kuang is the main founder and director of the Department of Assisted Reproduction at Shanghai Ninth People's Hospital affiliated with Shanghai Jiao Tong University School of Medicine. He is the Chairman of the Professional Committee on Reproductive Health of China Association of Rehabilitation Medicine.  Aimed for safe, effective, and simple ART techniques, he is one of the pioneers in promoting mild stimulation and natural cycles in IVF clinics in China.  He has established a new approach to performing luteal-phase ovarian stimulation.

Ge Lin.png

Ge Lin,M.D., Ph.D.

Professor Lin is a Vice-Director of the Key Laboratory of Human Stem Cell and Reproductive Engineering, National Health Commission of China. He has been the President of Reproductive and Genetic Hospital of CITIC-XIANGYA since 2017.  His research interests include human embryology, PGT, and human embryonic stem cell.  He and his colleagues firstly developed a next-generation sequencing platform for PGT, the “Microseq” technology to distinguish translocation carriers in the blastocyst, and produced the first cancer-free baby in China.  He was also involved in the work to establish the first human embryonic stem cell line and clinical applicable embryonic stem cell bank in China.  Professor Lin has published numerous peer-reviewed papers in international journals.


Yiping Shen, Ph.D.

Professor Shen, Ph.D., FACMG, FABMGG, is an Assistant Professor at Harvard Medical School and an associate at the Division of Genetics and Genomics, Boston Children's Hospital, a Co-Director of the Harvard Medical School Genetic Training Program course. He is a Fellow of the American College of Medical Genetics (ACMG), Certified by the American Board of Medical Genetics and Genomics (ABMGG) in 2005. His specialties include medical genetics, genetic testing, and genetic counseling.


Taosheng Huang, M.D., Ph.D.

Professor Huang is the Chief of Genetics for Pediatrics at SUNY Buffalo, Director of Genetics & Metabolism at Oishei Children’s Hospital.  His research focuses on discovering novel genes associated with mitochondrial diseases. In recent years, his group has identified many nuclear genes related to mitochondrial disease and new mtDNA mutations.  For novel disease-causing genes, his group has also established and characterized disease-causing genes with both an iPS cell model and a CRISPR/Cas9-produced mouse model for a better understanding of the molecular basis of pathogenesis and to develop treatments such as gene therapy. His research on mitochondrial replacement therapy was among the top 10 Science stories of 2016, and the discovery of biparental mtDNA inheritance was also ranked in the top 10 publications from 2019 by Nature. Now his laboratory also applies the discoveries from rare genetic diseases to more common diseases, such as cancer, diabetes, and preterm birth, and even to the biological basis of the aging process itself.  He was the immediate past president of the Association of Chinese Geneticists in America (ACGA) (2018-2021). Currently, he is a board director of the International Society of Reproductive Genetics.


Alan Thornhill, Ph.D.

Professor Thornhill is an honorary Professor in Reproductive Genetics at the University of Kent, Canterbury, UK, and was formerly Deputy Chair of the ESHRE PGD Consortium and Chair of Alpha, Scientists in Reproductive Medicine.  Between 2009 and 2015, Alan served as a Professional Member of the Human Fertilization and Embryology Authority, the UK body that regulates and licenses IVF, sitting on the Scientific and Clinical Advances Advisory Committee and chairing the Information for Quality Advisory group.  Alan's research interests include reproductive genetics, PGD, and improving the safety and effectiveness of IVF.   Currently, Professor Thornhill is Country Manager for Igenomix UK (part of the Vitrolife Group) with laboratories at the Surrey Research Park and a Senior Scientific Advisor for Igenomix international.  Prior to this, he was Associate Director in Illumina’s Reproductive and Genetic Health team, responsible for education and awareness in an IVF Market Development role within Europe, the Middle East, and Africa.



Carlos Simon, M.D., Ph. D.

Professor Simón is Board Certified and Full Professor of Ob/Gyn at the University of Valencia, Spain; Adjunct Professor, Department of Ob/Gyn, Baylor College of Medicine, USA; Head of the Scientific Board of Igenomix; and Senior Lecturer PT, BIDMC at Harvard University, Boston, MA, USA.  His main interest is in the understanding of the human embryonic implantation process considering as key elements of the embryo, the maternal endometrium, and the cross-communication between them.  He is the author of 471 publications in international peer-review journals and his H-Index in Google scholar is 103. Professor Simón is the editor of 19 books and has been the supervisor of 34 PhD Thesis.


Luca Generoli, M.D., Ph.D.

Professor Gianaroli has been a specialist in Reproductive Medicine since the end of the Seventies.  He is the Scientific Director of S.I.S.Me.R. (Italian Society for the Study of Reproductive Medicine) and holds the position of Scientific Director of I.I.A.R.G., the International Institutes of Advanced Reproduction and Genetics, and of IIRM SA. He is also an Honorary Professor at the School of Biosciences of the University of Kent.  He is the author of more than 250 papers in international scientific journals and the publisher or co-publisher of 9 books.  As of the date of this biosketch his H-index is 68. Professor Gianaroli has served as Chairman of the Italian Society of Reproduction and President of the European Society of Human Reproduction and Embryology (ESHRE).


Richard Scott, M.D.,HCLD

Professor Scott is a board-certified reproductive endocrinologist, embryologist, andrologist, and molecular genetics researcher.  He is a Founding Partner of IVIRMA Global.  He received his medical degree from the University of Virginia Medical School, Charlottesville, Virginia, performed his obstetrics and gynecology residency at Wilford Hall USAF Medical Center in San Antonio, Texas, and completed his fellowship in reproductive endocrinology at the Jones Institute for Reproductive Medicine in Norfolk, Virginia.  Professor Scott's research interests include reproductive senescence, embryology, preimplantation genetic screening and non-invasive screening of embryonic reproductive competence. He has published over 800 scientific papers and abstracts.


Angelina Beltsos, M.D.

Professor Beltsos is the CEO and Chief Medical Officer of Vios Fertility Institute. She is double board-certified in Obstetrics and Gynecology and in Reproductive Endocrinology and Infertility (REI), practicing medicine since 1991. She completed her residency in Obstetrics and Gynecology at Loyola University in 1995 followed by a fellowship in REI at Washington University in St. Louis, Missouri, completed in 1997. Dr. Beltsos is also the Medical Director of Vios and participates in a number of research projects and scientific publications every year. She has received numerous awards in teaching and has been honored as “Top Doctor” from Castle Connelly for several years. She is a popular speaker, both nationally and internationally, and a frequent media resource on the topic of infertility. She is the Executive Chairperson for the Midwest Reproductive Symposium International, an international conference of fertility experts. Her patients come from all over the U.S, and the globe.


Johan Smitz, M.D., Ph.D.

Professor Smitz is an Emeritus Professor at the Free Universiteit Brussel (VUB, Brussels, Belgium), an Honorary Professor at the University of San Marcos (Lima, Peru) and a Visiting Professor and Director of the Laboratory for Reproductive Biology and Oncofertility at the University Cayetano Heredia (Lima, Peru).  He has founded the Follicle Biology (FOBI) Research Laboratory at VUB since 1997 and has performed research in Assisted Reproduction Technologies for over 30 years. His current research projects are in vitro culture methods for human oocytes and follicles, non-invasive quality tests for human oocytes and embryos, and epigenetic safety testing in Assisted Reproduction by molecular methods.  He published more than 350 articles of which more than 100 were as first or senior authors. He is co-founder of two Spin-off biotech Companies of the Free University Brussels (VUB): Fertiga and Lavima Fertility with aim to bring non-invasive oocyte testing and hormone-free fertility therapies to the patient.


Keiichi Kato, M.D., PhD.

Dr. Kato is a board-certified specialist in reproductive medicine and obstetrics and gynecology. He is a General Director of Kato Ladies Clinic, Tokyo, Japan since 2013. He advocates the use of a natural cycle and minimal stimulation IVF to deliver safe, effective, and patient-friendly ART. In 2009, he joined Kato Ladies Clinic as a practicing infertility specialist. In 2015, he earned his Ph.D. in medicine from the School of Medicine of Kanazawa University.  Dr. Kato is a board of directors for the Japan Society of Fertilization and Implantation (JSFI) and the Japan Association of Private Assisted Reproductive Technology Clinics and Laboratories (Japan A-PART).



Catherine Racowsky, Ph.D., HCLD

Professor Racowsky is Director of the IVF Laboratory at Brigham & Women’s Hospital in Boston MA and Professor of Obstetrics and Gynecology at Harvard Medical School where she is on the promotions and retentions committee. She has served on the Society of Assisted Reproductive Technology (SART) Executive Council, the International Taskforce for Stem Cell Research, and several government oversight committees for reproductive medicine. She is the Past President of the New England Fertility Society and is the Past President of American Society of Reproductive Medicine (ASRM). She has published over 100 peer-reviewed papers on mammalian egg and embryo physiology and has co-edited five books.


Richard Paulson, M.D.

Professor Paulson is the Director of USC Fertility and has been with the practice since 1986. He is also a Professor of Obstetrics and Gynecology and Chief of the Division of Reproductive Endocrinology and Infertility at the University of Southern California Keck School of Medicine.  He has been rated one of “The Best Doctors in America” continuously since 1994. Professor Paulson has published several landmark investigations addressing the effect of age on female fertility, including the first observation that egg donation could be used to extend the reproductive lifespan in women over 40. Professor Paulson served as President of American Society for Reproductive Medicine (ASRM) and Pacific Coast Reproductive Society (PCRS).


Guanglun Zhuang, M.D.

Professor Zhuang (1936-2021) was a distinguished professor and expert in obstetrics and gynecology, and reproductive medicine.  He was the founder of the Center for Reproductive Medicine of the First Hospital of Sun Yat-sen University. He was the pioneer who applied egg donation artificial cycle to help patients with premature ovarian failure to obtain pregnancy and live delivery and single sperm intracytoplasmic injection to treat male infertility as well as preimplantation embryo genetic testing technique to obtain healthy IVF babies in China. Professor Zhuang was co-founder and the First President of the Global Chinese Reproductive Society.


Gorge E. Seidel, D.V.M., Ph.D.

Professor Seidel (1943-2021) was a distinguished professor and expert in reproductive medicine and made significant contributions to the international scientific, academic, medical, veterinary, embryo transfer, and biotechnology communities.  He received his BS in Dairy Science from Penn State in 1965 and both his MS (1968) and Ph.D. (1970) from Cornell University in Reproductive Physiology. In 1971, he joined the faculty of Colorado State University and founded their Embryo Transfer Lab in 1973. His dedication to animal agriculture was more than academic, from showing Ayrshire cattle during his youth to owning and managing an Angus cow-calf ranch operation at the time of his death. He was an appreciator of good science and an inspiring, nurturing mentor, pushing his students to realize what was possible. He was a member of numerous associations, including the National Academy of Sciences and the National Academy of Inventors. He was the founder and first President of International Society of Embryo Transfer (IETS).


Anthony Wynshaw-Boris, M.D., Ph.D.

Professor Wynshaw-Boris is Professor and Chair, Department of Genetics and Genome Sciences, School of Medicine of Case Western Reserve University, Division Chief, Genetics of University Hospitals Rainbow Babies and Children's Hospital, and Chairman, Department of Genetics of University Hospitals Cleveland Medical Center.  He focuses on understanding genetic and biochemical pathways important for the development and function of the mammalian central nervous system, primarily using mouse models and more recently induced pluripotent stem cells (iPSCs) of human and mammalian diseases to define pathways disrupted in these diseases. Professor Wynshaw-Boris is the Past President of American Society of Human Genetics (ASHG).


Bruce R. Korf, M.D., Ph.D.

Professor Korf is the Wayne H. and Sara Crews Finley Endowed Chair in Medical Genetics, Associate Dean for Genomic Medicine, UAB School of Medicine, Chief Genomics Officer, UAB Medicine, and Co-Director of the UAB-HudsonAlpha Center for Genomic Medicine. He is a medical geneticist, pediatrician, and child neurologist, certified by the American Board of Medical Genetics (clinical genetics, clinical cytogenetics, clinical molecular genetics), American Board of Pediatrics, and American Board of Psychiatry Neurology (child neurology).   He has served on the Board of Scientific Counselors of the National Cancer Institute and the National Human Genome Research Institute at the NIH. He chairs the Medical Advisory Committee of the Children's Tumor Foundation and serves on the CTF Board of Directors.


Yoshiharu Morimoto, M.D., Ph.D.

Professor Morimoto is the Chief Executive Officer and Chairman of IVF JAPAN Group which includes two infertility centers, IVF Namba Clinic and IVF Osaka Clinic with 5,000 IVF cycles yearly.  His main research field is in ultrastructural study on reproduction and mechanism of oocyte maturation. He practices integrated medicine including counseling, Quiong, acupuncture, and aromatherapy.  He holds a variety of academic and administrative positions. Professor Morimoto is the President of the Japan Society of Assisted Reproduction, Vice President of the Japanese Institution for Standardizing Assisted Reproductive Technology, and President-Elect of Asia Pacific Initiative Reproductive Endocrinology.


Kwang Yul Cha, M.D., Ph.D.

Dr. Cha is the Chair of CHA Global Institute for Bioscience and founder of CHA Biomedical Group, a global healthcare enterprise in Korea which owns and operates 81 medical centers and clinics and 15 bio-companies in 7 countries. As a physician-scientist, he achieved World’s first in-vitro maturation of the immature oocytes (IVM), human oocyte cryopreservation by vitrification, and establishment of cloned stem cell lines using adult somatic cells. World’s first IVM in human was featured in many famous reproductive medicine books including NOVAK. His achievements including the establishment of the first Egg-Banking were featured in TIMES magazine three times. He also published many medical reviews and over 200 peer-reviewed journal articles. Dr. Cha is also one of the founders of Asia’s first and most notably recognized academic society - Pacific Society for Reproductive Medicine.


Bill Yee, M.D.

Dr. Yee is Board Certified in both OB/GYN and Reproductive Endocrinology/Infertility.  He has been a pioneer in the field of in vitro fertilization since 1982, and his contributions include the first successful frozen embryo transfer resulting in a healthy baby in the United States.  He is well known for his expertise in the field of ultrasound.  He is also noted as the lead author of Transvaginal Sonography in Infertility.  Dr. Yee has served and held numerous leadership positions including president of the Society for Assisted Reproductive Technology (SART), board member of the American Society for Reproductive Medicine (ASRM), and an active deputy commissioner of the College of American Pathologists (CAP) for over twenty years which regulates IVF labs in the United States. In 1996, Dr. Yee co-founded the Pacific Society for Reproductive Medicine and is a permanent member of their Executive Council.



David Albertini, Ph.D.

Professor Albertini received his Ph.D. from Harvard University working on the cell biology of the mammalian ovary.  He was the Hall Professor of Molecular Medicine (Endowed Chair) at the Kansas University Medical Center where he continued his career long interests in the link between oocyte and embryo quality, especially as it pertains to the practice of human Assisted Reproduction Technologies. Since 2009, he has served as Editor-in-Chief of the Journal of Assisted Reproduction and Genetics, an official journal of the American Society for Reproductive Medicine. In 2020 he joined the Bedford Research Foundation where he is continuing his work on stem cells and women’s health.  He is the recipient of many awards including a Basil O’Connor fellowship from the March of Dimes, the Hammond Medal from the Society for Reproduction and Fertility (UK), and Founder’s Lectureship for the Australian Society of Reproductive Biology and is a Fellow of The International Society for In Vitro Fertilization. Professor Albertini has delivered more than 200 lectures worldwide and has served on scientific advisory boards or grant review councils in Australia, Belgium, Denmark, Scotland, Portugal, Ireland, Italy and the USA.


Yunxia Cao, M.D., Ph.D.

Professor Cao is the president of Anhui Medical University, director of the Department of Obstetrics and Gynecology, director of the Reproductive Medicine Center of the First Hospital of Anhui Medical University, and director of Anhui Fertility Preservation and Artificial Organ Engineering Technology Research Center. She published more than 100 SCI articles.  She has been working in the clinical, teaching, and scientific research line for nearly 30 years.


John L. Frattarelli, M.D.,HCLD

Dr. Frattarelli is board certified in Reproductive Endocrinology and Obstetrics & Gynecology.  He is the CEO and founder of Advanced Reproductive Medicine & Gynecology of Hawaii, Inc – DBA: Fertility Institute of Hawaii.  He also serves as the medical, practice, and laboratory director for the Fertility Institute of Hawaii. He is one of a few selected Reproductive Endocrinologists in the world who is also certified as a High Complexity Clinical Laboratory Director (HCLD).  He served as the Chief of Reproductive Endocrinology and the Medical and Practice Director for the Tripler ARMY IVF Institute in Honolulu, HI, from 2000 to 2006. From 2006 to 2008, Dr. Frattarelli was the Clinical Research Director with Reproductive Medicine Associates of New Jersey and an Associate Professor of Obstetrics and Gynecology at the Robert Wood Johnson Medical School in New Brunswick, NJ.  In 2008, he returned to Hawaii to found the Fertility Institute of Hawaii.  As an Assistant Clinical Professor at the University of Hawaii, he has mentored and educated many medical students and residents currently practicing in Hawaii. Dr. Frattarelli is the Past-President of the Pacific Coast Reproductive Society (PCRS), and he has served in several leadership roles for ACOG, ASRM, SREI, PCRS, and SART.  


Yanwen Xu, M.D., Ph.D.

Dr. Xu is the Chief Physician, Professor, Researcher, and Director of the Reproductive Center, in Reproductive Endocrinology, Department of Obstetrics and Gynecology, First Hospital of Sun Yat-sen University.  In 1999, she was the first to successfully establish the Preimplantation Genetic Diagnosis (PGD) technique in China, and then conducted a series of researches in related fields as the leader of the PGD project team.  She is currently the Vice-Chairman of the Youth Committee of the Reproductive Medicine Branch of the Chinese Medical Association and a member of the Reproductive Medicine Branch of the Guangdong Medical Association.


Wiwat Quangkananurug, M.D.

Dr. Quangkananurug is one of the most renowned fertility specialists in Thailand and has achieved successful pregnancy outcomes for many international patients who had previously despaired of ever having a child of their own.  He strives to do everything in his power to help all his patients conceive a baby and bring them great happiness.  He is always assessing new techniques, ideas, and methods and regularly attends fertility conferences overseas to maintain his position as a leading fertility expert.  Currently, Dr. Quangkananurug is the Fertility Specialist at Safe Fertility Group which have 5 clinics across Thailand. 


David Cram, Ph.D.

Dr. Cram has been an active research scientist at Monash University, Australia for over 25 years in the field of human genetics, IVF, stem cell and preimplantation genetic testing (PGT). He served as Director of PGD Services at Monash IVF from 1998-2008. Currently he holds the position of Head Genetics at Berry Genomics. Dr. Cram is the President of Preimplantation Genetic Diagnosis International Society (PGDIS).


Wei Ge, Ph.D.

Dr. Ge is a Chair Professor at the Faculty of Health Sciences (FHS) and the Director of the Centre of Reproduction, Development and Aging (CRDA), University of Macau. He also serves as the Vice Rector (Research) of the University. His primary research interest is reproductive biology, focusing on gonadal differentiation, ovarian folliculogenesis, reproductive aging and disease modeling. He uses zebrafish as the major animal model.


Vitaly A. Kushnir,  M.D.

Dr. Kushnir is a Reproductive Endocrinology & Infertility Specialist in Newport Beach, CA. As an internationally recognized fertility specialist, Dr. Kushnir has authored over 85 peer-reviewed manuscripts in leading medical journals and many book chapters on topics in reproductive endocrinology and infertility.  Dr. Kushnir serves as a Clinical Associate Professor of OBGYN at the University of California Irvine (UCI).  Prior to relocating to California, Dr. Kushnir practiced in New York City. He served as the Director of the Division of Reproductive Endocrinology and Infertility at Wyckoff Heights Medical Center.  He previously served as a consultant for the Division of Reproductive Health, Centers for Disease Control and Prevention (CDC). Dr. Kushnir is dual board-certified in Obstetrics & Gynecology, as well as Reproductive Endocrinology & Infertility.


Fuchou Tang, Ph.D.

Professor Tang is a full professor at BIOPIC, College of Life Sciences, Peking University. He is also Associate Director of Beijing Advanced Innovation Center for Genomics (ICG). His lab focuses on the epigenetic regulation of gene expression network during human early embryonic development and germline development. His lab pioneered the single cell sequencing field and has systematically developed a serial of single cell functional genomic sequencing technologies. His work has been cited for more than 11,000 times. He has been invited to give presentations at AGBT, ISSCR, ICHG, Gordon Conference, HCA.


Bo Liang, Ph.D.

Dr. Liang is the founder of Basecare Medical Corporation Limited, the first listed IVD company in the assisted-reproductive area in China. He developed the PGT-A testing kit, which is the first to achieve the “Class III medical device registration certificate” and the “innovative medical devices special approval" from NMPA in the reproductive area. He participated in compiling the Industry Standard and Guidelines on Evaluating the Quality Control Techniques for Pre-implantation Genetic Screening (High-throughput Sequencing method) in 2017. He is director of the provincial Research Center for Reproductive Genetic Technologies and Projects, Secretary-General of China’s Expert Committee on Genetic Counselling Capacity-building, and president of Suzhou Young Science and Technology Association.

Sijia Lu, Ph.D.

Dr. Lu is the co-inventor of MALBAC® (Multiple Annealing and Loopig Based Amplification Cycles) technology and co-founder of Yikon Medical Co., Ltd. With 30 international and national patents.  Dr. Lu has extensive experiences in the development and application of single-cell whole genome amplification (WGA) technology, and has invented NICS®Non-invasive Capacity Screening) technology.  Dr. Lu’s work has been published in many top-tier journals, including Science and Nature, and cited more than 4000 times world-wide. Under his leadership, Yikon Medical has developed a series of unique technical platforms that have been successfully used for single-cell whole genome sequencing, preimplantation genetic screening, preimplantation genetic diagnosis, prenatal genetic testing, and cancer diagnosis. Dr. Lu has received many national and international awards in recognition of his significant contribution to the field.


Jia Fei, M.S.

Mr. Fei is the founding board director and general manager of Jabrehoo, which is an integrated platform service company in reproduction health and genetics. He first applied high-throughput sequencing technology to assisted reproductive filed in China. He has pioneered a number of key technologies for preimplantation genetic testing and infertility genetic testing. He is a member of the infertility prevention and control professional group of the Reproductive Health Branch of the Chinese Preventive Medicine Association. He was rated as a high-end leading talent in Zhongguancun (2019) and the leading talent of Xinguomen (2020).


Janelle Luk, M.D.

Dr. Luk, one of the top board-certified Reproductive Endocrinologists in New York City, is breaking barriers in the world of IVF as the Medical Director at Generation Next Fertility. She specializes in creating individualized fertility treatments based on each patient’s needs. Her areas of expertise include diminished ovarian reserve, infertility of unknown etiology, polycystic ovarian syndrome, and recurrent pregnancy loss. In addition, Dr. Luk remains active in research within the field of reproductive endocrinology. She has published numrous reviews and research articles over her years of practice and has presented her research both nationally and internationally in China and Hong Kong. Dr. Luk received her Bachelor of Science at Cornell University and her medical degree from the Yale School of Medicine. She then completed her residency in OBGYN at Brigham and Women’s Hospital/Harvard Medical School and her fellowship in reproductive endocrinology and infertility at Yale School of Medicine.

bottom of page